0001415889-22-006704.txt : 20220617 0001415889-22-006704.hdr.sgml : 20220617 20220617160824 ACCESSION NUMBER: 0001415889-22-006704 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220615 FILED AS OF DATE: 20220617 DATE AS OF CHANGE: 20220617 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: ROSS ROBERT W. CENTRAL INDEX KEY: 0001733077 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40925 FILM NUMBER: 221023856 MAIL ADDRESS: STREET 1: C/O SURFACE ONCOLOGY STREET 2: 50 HAMPSHIRE ST., 8TH FLOOR CITY: CAMBRIDGE STATE: MA ZIP: 02139 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Xilio Therapeutics, Inc. CENTRAL INDEX KEY: 0001840233 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 851623397 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 828 WINTER STREET CITY: WALTHAM STATE: MA ZIP: 02451 BUSINESS PHONE: 617-833-1027 MAIL ADDRESS: STREET 1: 828 WINTER STREET CITY: WALTHAM STATE: MA ZIP: 02451 4 1 form4-06172022_010602.xml X0306 4 2022-06-15 0001840233 Xilio Therapeutics, Inc. XLO 0001733077 ROSS ROBERT W. 828 WINTER STREET SUITE 300 WALTHAM MA 02451 true false false false Stock Option (right to buy) 2.28 2022-06-15 4 A 0 26400 0 A 2032-06-14 Common Stock 26400 26400 D The option award was granted on June 15, 2022 and will vest in three equal installments on June 15, 2023, June 15, 2024 and June 15, 2025. /s/ Chris Frankenfield , Attorney-in-Fact 2022-06-17